Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review

Haiying Ding; Wenxiu Xin; Yinghui Tong; Jiao Sun; Gaoqi Xu; Ziqi Ye; Yuefeng Rao

doi:10.1371/journal.pone.0238536

Loading metrics

Open Access

Peer-reviewed

Research Article

Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review

Haiying Ding ,

Contributed equally to this work with: Haiying Ding, Wenxiu Xin

Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

Affiliations Department of Pharmacy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China, Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
⨯
Wenxiu Xin ,

Contributed equally to this work with: Haiying Ding, Wenxiu Xin

Roles Data curation, Formal analysis, Methodology, Writing – review & editing

Affiliation Department of Pharmacy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
⨯
Yinghui Tong,

Roles Data curation

Affiliation Department of Pharmacy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
⨯
Jiao Sun,

Roles Formal analysis

Affiliation Department of Pharmacy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
⨯
Gaoqi Xu,

Roles Formal analysis

Affiliation Department of Pharmacy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
⨯
Ziqi Ye,

Roles Writing – review & editing

Affiliation Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
⨯
Yuefeng Rao

Roles Conceptualization, Supervision, Writing – review & editing

* E-mail: raoyf@zju.edu.cn

Affiliation Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

http://orcid.org/0000-0002-3098-2768

⨯

Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review

Haiying Ding,
Wenxiu Xin,
Yinghui Tong,
Jiao Sun,
Gaoqi Xu,
Ziqi Ye,
Yuefeng Rao

Published: September 2, 2020
https://doi.org/10.1371/journal.pone.0238536

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.
Health economics
Is the Subject Area "Health economics" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.